Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950156-13-000020)

Filing Details

Accession Number:: 0000950156-13-000020
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-14 17:04:31
Reporting Period:: 2013-01-02

Filing Date:: 2013-03-14
Accepted Time:: 2013-03-14 17:04:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
352998	Igi Laboratories Inc	IG	Biological Products, (No Disgnostic Substances) (2836)	010355758

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1467550	B. Michael Hemric	5603 Versailles Court Colleyville TX 76034		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-03-06	4,998	$1.14	7,883	No	4	P	Direct
Common Stock	Acquisiton	2013-03-07	7,639	$1.15	15,522	No	4	P	Direct
Common Stock	Acquisiton	2013-03-08	1,532	$1.18	17,054	No	4	P	Direct
Common Stock	Acquisiton	2013-03-11	468	$1.18	17,522	No	4	P	Direct
Common Stock	Acquisiton	2013-03-11	3,000	$1.21	20,522	No	4	P	Direct
Common Stock	Acquisiton	2013-03-12	900	$1.34	21,422	No	4	P	Direct
Common Stock	Acquisiton	2013-03-12	2,100	$1.34	23,522	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2013-01-02	10,000	$0.00	10,000	$1.04
Common Stock	Stock Option	Acquisiton	2013-01-02	15,000	$0.00	15,000	$1.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2014-01-02	2023-01-02	No	4	A	Direct
15,000	2014-01-02	2023-01-02	No	4	A	Direct

Footnotes

These securities were granted as part of the Issuer's annual equity compensation to its non-employee directors under the Issuer's 1999 Director Stock Option Plan.